Canada markets closed

Integra LifeSciences Holdings Corporation (IART)

NasdaqGS - NasdaqGS Real Time Price. Currency in USD
Add to watchlist
28.41-0.97 (-3.30%)
At close: 04:00PM EDT
28.57 +0.16 (+0.56%)
After hours: 06:51PM EDT
Currency in USD

Valuation Measures4

Market Cap (intraday) 2.23B
Enterprise Value 3.61B
Trailing P/E 33.82
Forward P/E 8.88
PEG Ratio (5 yr expected) 0.74
Price/Sales (ttm)1.48
Price/Book (mrq)1.41
Enterprise Value/Revenue 2.34
Enterprise Value/EBITDA 14.09

Trading Information

Stock Price History

Beta (5Y Monthly) 1.14
52-Week Change 3-48.64%
S&P500 52-Week Change 321.08%
52 Week High 356.21
52 Week Low 327.18
50-Day Moving Average 335.83
200-Day Moving Average 339.69

Share Statistics

Avg Vol (3 month) 3769.61k
Avg Vol (10 day) 31.11M
Shares Outstanding 578.6M
Implied Shares Outstanding 678.6M
Float 867.22M
% Held by Insiders 113.81%
% Held by Institutions 188.31%
Shares Short (Apr 15, 2024) 42.61M
Short Ratio (Apr 15, 2024) 43.86
Short % of Float (Apr 15, 2024) 43.85%
Short % of Shares Outstanding (Apr 15, 2024) 43.33%
Shares Short (prior month Mar 15, 2024) 42.21M

Dividends & Splits

Forward Annual Dividend Rate 4N/A
Forward Annual Dividend Yield 4N/A
Trailing Annual Dividend Rate 30.00
Trailing Annual Dividend Yield 30.00%
5 Year Average Dividend Yield 4N/A
Payout Ratio 40.00%
Dividend Date 3N/A
Ex-Dividend Date 4N/A
Last Split Factor 22:1
Last Split Date 3Jan 04, 2017

Financial Highlights

Fiscal Year

Fiscal Year Ends Dec 31, 2023
Most Recent Quarter (mrq)Dec 31, 2023

Profitability

Profit Margin 4.39%
Operating Margin (ttm)19.12%

Management Effectiveness

Return on Assets (ttm)4.24%
Return on Equity (ttm)3.99%

Income Statement

Revenue (ttm)1.54B
Revenue Per Share (ttm)19.25
Quarterly Revenue Growth (yoy)-0.20%
Gross Profit (ttm)N/A
EBITDA 383.57M
Net Income Avi to Common (ttm)67.74M
Diluted EPS (ttm)0.84
Quarterly Earnings Growth (yoy)-62.50%

Balance Sheet

Total Cash (mrq)309.1M
Total Cash Per Share (mrq)3.95
Total Debt (mrq)1.68B
Total Debt/Equity (mrq)106.02%
Current Ratio (mrq)3.45
Book Value Per Share (mrq)20.31

Cash Flow Statement

Operating Cash Flow (ttm)139.96M
Levered Free Cash Flow (ttm)177.7M